Literature DB >> 24617517

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.

Valérie Pittet1, Gerhard Rogler, Christian Mottet, Florian Froehlich, Pierre Michetti, Philippe de Saussure, Bernard Burnand, John-Paul Vader.   

Abstract

BACKGROUND: Despite the chronic and relapsing nature of inflammatory bowel diseases (IBD), at least 30% to 45% of the patients are noncompliant to treatment. IBD patients often seek information about their disease. AIM: To examine the association between information-seeking activity and treatment compliance among IBD patients. To compare information sources and concerns between compliant and noncompliant patients.
METHODS: We used data from the Swiss IBD cohort study, and from a qualitative survey conducted to assess information sources and concerns. Crude and adjusted odds ratios (OR) for noncompliance were calculated. Differences in the proportions of information sources and concerns were compared between compliant and noncompliant patients.
RESULTS: A total of 512 patients were included. About 18% (n = 99) of patients were reported to be noncompliant to drug treatment and two-thirds (n = 353) were information seekers. The OR for noncompliance among information seekers was 2.44 (95%CI: 1.34-4.41) after adjustment for confounders and major risk factors. General practitioners were 15.2% more often consulted (p = 0.019) among compliant patients, as were books and television (+13.1%; p = 0.048), whereas no difference in proportions was observed for sources such as internet or gastroenterologists. Information on tips for disease management were 14.2% more often sought among noncompliant patients (p = 0.028). No difference was observed for concerns on research and development on IBD or therapies.
CONCLUSION: In Switzerland, IBD patients noncompliant to treatment were more often seeking disease-related information than compliant patients. Daily management of symptoms and disease seemed to be an important concern of those patients.

Entities:  

Keywords:  Crohn's disease; compliance to treatment; information concerns; information seeking; ulcerative colitis

Mesh:

Year:  2014        PMID: 24617517     DOI: 10.3109/00365521.2014.896408

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Multiscale analysis of the murine intestine for modeling human diseases.

Authors:  Jesse Lyons; Charles A Herring; Amrita Banerjee; Alan J Simmons; Ken S Lau
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

2.  Associations Between Patient Characteristics and the Amount of Arthritis Medication Information Patients Receive.

Authors:  Lorie Love Geryk; Susan Blalock; Robert F DeVellis; Kristen Morella; Delesha Miller Carpenter
Journal:  J Health Commun       Date:  2016-09-26

3.  Internet Searches About Therapies Do Not Impact Willingness to Accept Prescribed Therapy in Inflammatory Bowel Disease Patients.

Authors:  Alexandra Feathers; Tommy Yen; Laura Yun; Garrett Strizich; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2015-12-10       Impact factor: 3.199

4.  Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn's Disease Patients in Clinical Remission.

Authors:  Caterina Viganò; Roberta Calzolari; Paola Marianna Marinaccio; Cristina Bezzio; Federica Furfaro; Gabriella Ba; Giovanni Maconi
Journal:  Gastroenterol Res Pract       Date:  2015-12-28       Impact factor: 2.260

5.  Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease.

Authors:  Yifei Liu; Joakim Söderberg; Jingdong Chao
Journal:  Pharmacy (Basel)       Date:  2022-07-20

6.  Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?

Authors:  Valérie Pittet; Carla Vaucher; Michel H Maillard; Marc Girardin; Philippe de Saussure; Bernard Burnand; Gerhard Rogler; Pierre Michetti
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.